The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

Alexander A Berezin; Zeljko Obradovic; Ivan M Fushtey; Tetiana A Berezina; Evgen V Novikov; Lukas Schmidbauer; Michael Lichtenauer; Alexander E Berezin

doi:10.3390/biomedicines11020457

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

Alexander A Berezin, Zeljko Obradovic, Ivan M Fushtey, Tetiana A Berezina, Evgen V Novikov, Lukas Schmidbauer, Michael Lichtenauer (Co-Autor/-in), Alexander E Berezin

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

10 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	BIOMEDICINES
Jahrgang	11
Ausgabenummer	2
DOIs	https://doi.org/10.3390/biomedicines11020457
Publikationsstatus	Veröffentlicht - 2023

Zugriff auf Dokument

10.3390/biomedicines11020457

Dieses zitieren

@article{62361decc59c4cd1a6c1aa617fbafdb8,

title = "The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.",

keywords = "GLUCOSE COTRANSPORTER-2 INHIBITORS, REDUCED EJECTION FRACTION, DISEASE, IRISIN, RISK, HOMEOSTASIS, MORTALITY, OBESITY",

author = "Berezin, {Alexander A} and Zeljko Obradovic and Fushtey, {Ivan M} and Berezina, {Tetiana A} and Novikov, {Evgen V} and Lukas Schmidbauer and Michael Lichtenauer and Berezin, {Alexander E}",

note = "Lichtenauer, AE Berezin, Schmidbauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.",

year = "2023",

doi = "10.3390/biomedicines11020457",

language = "English",

volume = "11",

journal = "BIOMEDICINES",

issn = "2227-9059",

publisher = "MDPI",

number = "2",

}

TY - JOUR

T1 - The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

AU - Berezin, Alexander A

AU - Obradovic, Zeljko

AU - Fushtey, Ivan M

AU - Berezina, Tetiana A

AU - Novikov, Evgen V

AU - Schmidbauer, Lukas

AU - Lichtenauer, Michael

AU - Berezin, Alexander E

N1 - Lichtenauer, AE Berezin, Schmidbauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

PY - 2023

Y1 - 2023

KW - GLUCOSE COTRANSPORTER-2 INHIBITORS

KW - REDUCED EJECTION FRACTION

KW - DISEASE

KW - IRISIN

KW - RISK

KW - HOMEOSTASIS

KW - MORTALITY

KW - OBESITY

U2 - 10.3390/biomedicines11020457

DO - 10.3390/biomedicines11020457

M3 - Original Article

C2 - 36830993

SN - 2227-9059

VL - 11

JO - BIOMEDICINES

JF - BIOMEDICINES

IS - 2

ER -